Here's What AstraZeneca's Recent FDA News Means for Shareholders

Here's What AstraZeneca's Recent FDA News Means for Shareholders

Submitted by admin on May 30, 2022 - 10:15am
Source: 
Motley Fool
News Tags: 
AstraZeneca
FDA
Imfinzi
tremelimumab
liver cancer
Headline: 
Here's What AstraZeneca's Recent FDA News Means for Shareholders
snippet: 
  • Tremelimumab and Imfinzi may have an addressable market in the tens of thousands of patients.
  • The potential drug pairing could top $1 billion in sales for AstraZeneca.
  • The stock seems like a good buy at this time for investors with a long-term mindset.

Do Not Allow Advertisers to Use My Personal information